Walder Wyss advised Raiffeisen Switzerland Cooperative in connection with its role as original lender, coordinator and security agent in the financing of Halphamicron Holding, leading to the acquisition of Vasconi SA, TS Décolletage SA
Search Results for: Walder Wyss
Swiss clinical-stage radiopharmaceutical company Nuclidium completed a Series B financing round, raising CHF 79 million (EUR 84 million). Vischer advised Nuclidium throughout the operation, while Walder Wyss advised Angelini Ventures, Kurma Partners and Wellington Partners, in connection
Walder Wyss advised Energie 360° on its acquisition of Move Mobility from VISCHER acted as legal counsel to Primeo Energie, Groupe E and ewb. In connection with the deal Vischer advised the selling parties .Headquartered in
Walder Wyss advised CPM Partners’ founders and shareholders on the sale of a majority stake to funds advised by investment firm Deutsche Private Equity. CPM Partners is a consulting and technology services company specialised in
Software and cloud solutions specialist SoftwareOne through completion of its recommended voluntary share and cash offer for all issued shares in Crayon. the deal Following fulfilment of the last closing condition, SoftwareOne has settled the
Niederer Kraft Frey (NKF) advised Vision Group on its merger with LensOnline. In connection with the transaction, NKF also advised on securing new financing from arranger, agent and lender UBS Switzerland. Moreover, Advestra advised UBS
Walder Wyss advised Boostbar, a Switzerland- and UK-based company specialising in unattended retail technology, on its EUR 16 million Series B equity financing round. Direttissima Growth Partners led the round in question, with participation from Capmont
Walder Wyss advised the investors in Mosanna Therapeutics’ Series A financing round EQT Life Sciences and Pivotal bioVenture Partners led the round in question, along with Forbion, Broadview Ventures and Norwest as co-lead investors. Returning
Advoro and Walder Wyss advised Helvetica Property Investors in connection with the merger of Helvetica Swiss Opportunity Fund into Helvetica Swiss Commercial Fund. The context Pursuant to the consolidation, the HSO Fund was delisted from
Welcome to “signed sealed weekend”, our inside track on what’s happening in the Swiss legal market. Without further ado, let’s go through our news highlights of the week. In January 2025, Laurent Killias (pictured
